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Abstract
We examined the involvement of thyrotropin-releasing hor-
mone (TRH) and TRH type 1 and 2 receptors (TRH-R1 and
TRH-R2, respectively) in the regulation of hypothalamic neu-
ronal histamine. Infusion of 100 nmol TRH into the rat third
cerebroventricle (3vt) signiﬁcantly decreased food intake
(p < 0.05) compared to controls infused with phosphate-
buffered saline. This TRH-induced suppression of food intake
was attenuated partially in histamine-depleted rats pre-treated
with a-ﬂuoromethylhistidine (a speciﬁc suicide inhibitor of
histidine decarboxylase) and in mice with targeted disruption
of histamine H1 receptors. Infusion of TRH into the 3vt in-
creased histamine turnover as assessed by pargyline-induced
accumulation of tele-methylhistamine (t-MH, a major meta-
bolite of neuronal histamine in the brain) in the tubero-
mammillary nucleus (TMN), the paraventricular nucleus, and
the ventromedial hypothalamic nucleus in rats. In addition,
TRH-induced decrease of food intake and increase of hista-
mine turnover were in a dose-dependent manner. Microinfu-
sion of TRH into the TMN increased t-MH content, histidine
decarboxylase (HDC) activity and expression of HDC mRNA
in the TMN. Immunohistochemical analysis revealed that
TRH-R2, but not TRH-R1, was expressed within the cell
bodies of histaminergic neurons in the TMN of rats. These
results indicate that hypothalamic neuronal histamine medi-
ates the TRH-induced suppression of feeding behavior.
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Thyrotropin-releasing hormone (TRH) plays a fundamental
role in the regulation of anterior pituitary TSH secretion
(Yarbrough 1979). The endocrine function of TRH is
supported by TRH type 1 receptors (TRH-R1) that are
localized predominantly to hypothalamic regions. In addition,
TRH-R1 expressed in other regions, such as the brain stem
and spinal cord support a functional link between TRH and
vegetative and autonomic functions. In contrast to the
expression of TRH-R1, TRH type 2 receptor (TRH-R2)
mRNA is distributed widely throughout the brain, including
the thalamus, cerebral and cerebellar cortex, and the reticular
formation. This distribution of TRH-R2 indicates that TRH is
involved in higher cognitive functions as well as in regulating
the arousal system, locomotor activity, and pain perception.
It was suggested recently that leptin plays an important
role in the neuroendocrine regulation of the hypothalamic–
pituitary–thyroid axis (Ahima et al. 1996; Legradi et al.
1997; Nillni and Sevarino 1999). TRH gene expression in the
paraventricular nucleus (PVN) has been shown to be
regulated by leptin (Flier and Maratos-Flier 1998; Mantzoros
1999; Nillni et al. 2000). In addition, neurons in the PVN
that release TRH express both leptin and melanocortin-4
receptors, which suggests that TRH is an important part of
the signaling systems that regulate feeding behavior. In line
with this hypothesis, acute central administration TRH was
reported to have anorexigenic effects (Vogel et al. 1979;
Morley and Levine 1980; Breese et al. 1981).
Histamine is a neurotransmitter that regulates appetite,
energy metabolism, body temperature, and the sleep–wake
cycle (Doi et al. 1994; Sakata et al. 1997; Huang et al. 2001,
2006). We demonstrated previously that neuronal histamine
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  2007 The Authorssuppressed food intake via H1 receptors within the PVN and
ventromedial hypothalamus (VMH) (Fukagawa et al. 1989).
Furthermore, hypothalamic neuronal histamine is one of the
hypothalamic targets of leptin, as indicated by the observation
that leptin accelerates the release of neuronal histamine within
the hypothalamus (Yoshimatsu et al. 2001). Leptin-induced
suppression of feeding is attenuated both in rats in which
histamine has been depleted by a-ﬂuoromethylhistidine
(FMH), a suicide inhibitor of histamine synthesizing histidine
decarboxylase (HDC) enzyme as well as in mice with targeted
disruption of histamine H1 receptors (H1KO mice) (Yoshi-
matsu et al. 1998; Masaki et al. 2001). In contrast to the
functional connection between histamine and leptin, little is
known about how leptin activates neuronal histamine because
the long form of the leptin receptor is not expressed by
histaminergic neurons within the tuberomammillary nucleus
(TMN) (Elmquist et al. 1998). As stated above, leptin elicits
the expression of TRH in the PVN (Legradi et al. 1997). In
addition, TRH immunoreactivity has been identiﬁed in some
histamine-containing neurons within the TMN (Airaksinen
et al. 1992). The aforementioned ﬁndings suggest that TRH
might mediate leptin signaling to histaminergic neurons.
In the present study, we examined the neuroanatomical
and functional relationship between TRH and neuronal
histamine. We tested whether histamine depletion and
targeted disruption of histamine H1 receptors attenuated the
anorexic effects of TRH, if TRH increased histamine
turnover within hypothalamic nuclei that are involved in
energy homeostasis, and whether TRH receptors were
expressed in histaminergic neurons within the TMN.
Materials and methods
Animals
We used adult (250–280 g) male Sprague–Dawley rats (Seac
Yoshitomi, Fukuoka, Japan), and adult (25–30 g) male H1KO mice
(C57BL/6 background). H1KO mice were generated by homoge-
neous recombination as described previously (Inoue et al. 1996).
Animals were housed in a room illuminated daily from 7 AM to 7 PM
(12 h light–dark cycle) at a temperature of 21 ± 1 C and 55 ± 5%
relative humidity. Animals were allowed free access to standard rat
chow (CE-2; Clea Japan, Tokyo, Japan) and tap water. All rats were
handled for 5 min on four successive days prior to each experiment
to equilibrate the level of arousal (Sakata 1982). All studies were
conducted in accordance with Oita University Guidelines for
Animal Care, which are based on the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Surgery
Under anesthesia (50 mg/kg sodium pentobarbital, i.p.), rats were
placed in a stereotaxic apparatus (Narishige, Tokyo, Japan). A
stainless steel guide cannula (23-gauge) was implanted chronically
into the third cerebroventricle (3vt). This procedure was carried out at
least 10 days before the start of infusions. A stainless steel wire stylet
(30-gauge) was inserted into the guide cannula to prevent leakage of
the CSF and obstruction of the cannula. A stainless steel cannula (23-
gauge; 15 mm long) was inserted into the 3vt along the midline
6.0 mm anterior to the zero ear bar coordinate to a depth of 7.8 mm
from thecortical surfaceaccording to theatlas ofPaxinos and Watson
(Paxinos and Watson 1986). Similarly, at least 1 week prior to the
start of infusions, a cannula was implanted into the lateral
cerebroventricle (lvt) of the mice 1.0 mm lateral from the midline
and 0.22 mm posterior to the bregma at a depth of 2.0 mm from the
cortical surface according to the atlas of Franklin and Paxinos
(Franklin and Paxinos 1997). Details of the aforementioned surgical
procedures have been described previously (Sakata et al. 1981).
Drugs
TRH (10 lmol/mL), pargyline hydrochloride (0.33 mmol/kg), and
FMH (50 mg/mL) (Sigma, St Louis, MO, USA) were dissolved in
phosphate-buffered saline (PBS). Each solution was prepared
freshly on the day of administration. The pH of each solution was
adjusted to 6.5–7.5.
Measurement of food intake
Change in food intake by different doses of TRH
Rats (n = 24) were divided into four groups (n = 6 per group). Food
wasremoved24 hbeforetheexperiment.Onthedayoftheexperiment,
TRH (100 nmol/10 lL/10 min),TRH(10 nmol/10 lL/10 min),TRH
(1 nmol/10 lL/10 min) or PBS were centrally infused. Food intake
was measured for 1 h following the infusion of TRH or PBS.
Changes in food intake regulated by TRH after histamine depletion
Rats (n = 24) that were matched on the basis of body mass were
allocated to one of four treatment groups (n = 6 rats per group).
Food was removed 24 h before the experiment. On the day of the
experiment, an equivalent volume of FMH (50 mg/kg) or PBS was
administered (i.p.) 1 h before central infusion of TRH (100 nmol/
10 lL/10 min) or PBS (10 lL/10 min). Food intake was measured
for 1 h following the infusion of TRH or PBS.
Changes in food intake regulated by TRH in H1KO mice
Food was removed 24 h before the experiment. On the day of the
experiment, TRH (10 nmol/lL) or PBS was infused via the lvt into
H1KO (n = 12) or wild-type mice (n = 12) at a rate of 1.0 lL/min
for 1 min. Food intake was measured for 1 h following the infusion
of TRH or PBS.
Measurement of hypothalamic histamine and tele-methylhistamine
content after central infusion of TRH or FMH
Rats were pre-treated with pargyline hydrochloride (0.33 mmol/kg,
i.p.), an inhibitor of monoamine oxidase B which induced
accumulation of tete-methylhistamine (t-MH) in the extraneural
space as a major metabolite of released neuronal histamine 90 min
before the central infusion of either TRH (100 nmol/10 lL/10 min),
TRH (10 nmol/10 lL/10 min), TRH (1 nmol/10 lL/10 min), or
PBS (10 lL/10 min). Different doses of TRH or PBS was infused
centrally at a rate of 1 lL/min for 10 min to each group. Additional
rats (n = 12) were divided into two groups (n = 6 per group). FMH
(50 mg/kg) or PBS was intraperitoneally administered.
All rats were anesthetized with sodium pentobarbital (50 mg/kg,
i.p.) before being exsanguinated by transcardiac perfusion with
100 mL saline that contained 200 units of heparin. After decapi-
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frozen in liquid nitrogen. Brain regions that contained the lateral
hypothalamus, PVN, VMH, and TMN were dissected using a frozen
razor blade. The dissected tissue was submerged in 400 lL 0.5 M
acetic acid before being homogenized. The homogenate was boiled
for 10 min before a 50-lL sample was removed for a protein assay
(Bio-Rad Laboratories, Hercules, CA, USA). Histamine content was
measured in 50-lL samples using a histamine radioimmunoassay
(RIA) kit (Eikenkagaku, Tokyo, Japan). The concentration of t-MH
in each sample was measured in a 40-lL sample using a t-MH RIA
kit (Pharmacia Upjohn, Tokyo, Japan), except FMH-infused group.
Measurement of HDC activity in the TMN and t-MH contents in the
TMN, anterior hypothalamus and cortex after microinfusion of TRH
into the TMN
Rats (n = 24) were used to measure HDC activity and brain t-MH
levels following perfusion of TRH or PBS (6 rats per group) and
additional 6 rats were used to verify the precise position of infusion.
Allratswereanesthetizedwithsodiumpentobarbital(50 mg/kg,i.p.),
placed in stereotaxic apparatus and unilaterally implanted with a
stainless steel guide cannula (23-gauge; 15 mm long). TMN
coordinates was )4.3 mm from bragma, lateral 1.5 mm to the
midbrain, 8.0 mm below the cortical surface, according to the atlas of
Paxinos and Watson (Paxinos and Watson 1986). Each guide cannula
was placed with its tip 1 mm above its target site (unilateral side). A
stainless wire stylet (29 gauge) was placed in the guide cannula until
the testing day. A 16-mm-long infusion cannula (29 gauge) was
unilaterally inserted into the guide cannula 30 min before testing so
that the tip of the infusion cannula protruded 1 mm beyond the tip of
theguidecannula.Onthetestingday,all ratswere ascertained tohave
recovered to at least the pretreatment body weight. TRH (10 nmol/
lL) or PBS was infused at the rate of 0.2 lL /min for 5 min (1 lL).
Brain was removed and sections containing the TMN, anterior
hypothalamus (AH) and cerebral cortex were dissected with a frozen
razorblade. After homogenization, the concentration of tele-methyl-
histamine(t-MH)ineachsamplewasmeasuredusingat-MHRIAkit.
Rats treated with TRH (10 nmol/lL) or PBS (n = 6 per group)
were used to measure the HDC activity in the TMN. HDC activity
was evaluated by measuring the formation of histamine from L-
histidine in the sample. After homogenization with 400 lL PBS and
centrifugation at 1000 g, the reaction was started by addition of L-
histidine (0.25 mmol/L) to the sample, incubated for 1 h. Histamine
concentration was measured using a histamine RIA kit. Brains of the
remaining rats (n = 6) were ﬁxed by 4% paraformaldehyde and cut
into 40-lm coronal sections through TMN.
Quantitative detection of rat HDC mRNA in the TMN by real-time
reverse transcription polymerase chain reaction
On the testing day, TRH (1 nmol/lL), TRH (10 nmol/lL), TRH
(50 nmol) or PBS was infused at the rate of 0.2 lL /min for 5 min
(1 lL). Brain was removed and the section containing the TMN was
dissected with a frozen razorblade. One-tube RT-PCR was per-
formed using the Qiagen (Valencia, CA, USA) one-tube RT-PCR kit
according to manufacturer’s recommendations. Primer sets included
5¢-CCCAGTGAATACCATGAATAC-3¢ (sense) and 5¢-ATGTCC-
CCAAAGATGCTA-3¢ (antisense) for rat HDC determination
(designed based on GenBank accession number M29591). RT was
performed at 50 C for 30 min. followed 40 cycles of PCR (95 C
30 s, 55 C3 0s ,7 2  C 30 s). Expression of each target gene was
normalized to total RNA and samples run in triplicate. The standard
curve samples used for RT-PCR were prepared by serial dilution of a
RNA sample of known concentration to cover the range of 3000 to
3 ng. The log-linear portion of the standard curve was identiﬁed and
regression coefﬁcient R
2 equaled 1.00. Threshold cycle (Ct) data
were used to determine the amount of each target gene in the
hypothalamus. DCt was deﬁned as the average Ct value for PBS,
TRH (1 nmol), TRH (10 nmol) or TRH (50 nmol) group, respec-
tively. The percent change in expression, relative to the chow group,
was deﬁned as 2 –DDCt · 100, where DDCt equals the group DCt
minus the DCt of PBS group. The SE of the DDCt is considered the
same as the SE of the DCt value because the calculation of DDCt is
subtraction of an arbitrary constant.
Immunohistochemistry
Rats were anesthetized with sodium pentobarbital (50 mg/kg, i.p.)
before being exsanguinated by transcardiac perfusion with 50 mL
saline that contained 50 units of heparin. This was followed by
transcardiacperfusionwith300 mL4%paraformaldehydeinice-cold
PBS. The brain was removed and divided into three segments
(forebrain, diencephalon, and brain stem). The diencephalon was
stored in PBS overnight. The tissue was then submerged in a 20%
sucrosesolutionfor2 days,followedbysubmersionina30%sucrose
solution for 3 days. Thereafter, the tissue was snap-frozen at )80 C
before being sectioned at a thickness of 30 lm with a cryostat at
)20 C. Sections were treated with 0.3% H2O2 in PBS for 30 min
before being pre-soaked for 1 h in PBS that contained 0.3% Triton
X-100 (Sigma), 2% bovine serum albumin, and 2% normal goat
serum. The sections were incubated overnight at 4 C with polyclonal
rabbit antiserum recognizing TRH-R1 or TRH-R2 (speciﬁcity for rat,
1 : 500; Santa Cruz Biotechnology Inc., CA, USA), followed by
detection with biotin-conjugated goat anti-rabbit IgG and FITC-
conjugated streptoavidin (ABC reagent; Vector Laboratories, Burlin-
game,CA,USA).Sectionswerethenincubatedovernightat4 Cwith
polyclonal rabbit antiserum recognizing HDC (speciﬁcity for rat,
1 : 2000; Chemicon Inc., Temecula, CA, USA) in a buffer that
contained 0.3% Triton X-100 and 1% NGS. Sections were subse-
quently exposed to biotin-conjugated goat anti-rabbit IgG (ABC
reagent; Vector Laboratories) and Rhodamine-conjugated streptoavi-
din (ABC reagent; Vector Laboratories). Negative control (single
stainingforHDC)wasperformedineachexperiment,inwhichoneof
the primary antibodies (TRH-R1 or TRH-R2) was replaced with the
normal serum, and further incubation with both secondary antibodies
was performed as usual. Stained sections were examined with a
confocal immunoﬂuorescence microscope (Olympus, Tokyo, Japan).
The area immunostained by antibodies were analyzed with a
computed image analyzer (Lumina Vision, Mitsutani Corp.
Kyoto, Japan). Rhodamine-stained area and FITC-stained area were
visualized as red and green signals, respectively. The results are
computer images of the same section that can be manipulated using
reconstruction technique. Images were not adjusted or altered in any
way, except for occasional adjustment of brightness.
Statistics
Data are expressed as the mean ± SE. Differences were analyzed
using ANOVA followed by Fisher’s protected least-signiﬁcant
difference post hoc test. Signiﬁcance was established at p < 0.05.
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Dose–response of TRH on food intake and contents of
histamine and t-MH in the TMN
The central infusion of TRH at 100 and 500 nmol doses
resulted in signiﬁcant reduction of 1-hr food intake by
about 50% (1.80 ± 0.36 vs. 3.85 ± 0.45 g and 1.17 ± 0.17
vs. 3.85 ± 0.45 g, respectively), compared to PBS
(p < 0.05 and 0.01, respectively). Furthermore, TRH at
the dose of 10–500 nmol decreased food intake in a
dose-dependent manner. However, no signiﬁcant
suppression of 1-hr food intake was observed at 10 nmol
of TRH, compared to PBS (3.27 ± 0.3 vs. 3.85 ± 0.45 g)
(Fig. 1a).
We also examined the effect of different doses of TRH
on histamine metabolism in the TMN of rats. As shown in
Fig. 1b and c, the central infusion of TRH at 100 and
500 nmol doses increased histamine and t-MH contents in
the TMN but not at 10 nmol of TRH (Fig. 1b and c).
Thus, 100 nmol was the minimal effective dose of TRH to
suppress feeding and increase histamine turnover in
this experiment. Moreover, histamine and t-MH contents
were also increased in a dose-dependent manner (Fig. 1b
and c).
Histamine content in the TMN after the FMH
administration
Histamine content in the TMN after the administration of
FMH (50 mg/kg) was signiﬁcantly reduced by 73% in rats
(p < 0.05) (Fig. 2). Therefore, FMH at 50 mg/kg dose is
enough to deplete neuronal histamine in the TMN of the rat
hypothalamus.
Attenuation of the anorexic effects of TRH in
histamine-depleted rats and H1KO mice
Food intake in rats whose hypothalamic histamine content
was increased by bolus administration of TRH (100 nmol)
into the 3vt (1.34 ± 0.43 g) was lower (p < 0.01) than that
in control (PBS-treated) rats (4.14 ± 0.29 g; n = 6 per
group). This anorexic effect of TRH was signiﬁcantly
attenuated by pretreatment with FMH, which was associ-
ated with a signiﬁcantly smaller reduction in food intake
(a)
(b)
(c)
Fig. 1 Dose effect of TRH on food intake and histamine contents in
the TMN. (a) Food intake over 1 h in rats (n = 6 per group) after the
central infusion of TRH at 10, 100 or 500 nmol or PBS. *p < 0.05
versus, **p < 0.01 versus PBS and TRH (10 nmol), #p £ 0.05 versus
TRH (100 nmol). 3vt infusion of TRH at 100 and 500 nmol elevated
the contents of histamine (b) and t-MH (c) in the TMN. (b) Histamine
concentrations in the TMN of rats (n = 6 per group) treated by 3vt
infusion with PBS or TRH (10, 100, or 500 nmol). (c) Concentrations of
t-MH in the TMN of rats treated as described for (c). *p < 0.05 versus
PBS and TRH (10 nmol), **p < 0.01 versus PBS and TRH (10 nmol),
#p £ 0.05 versus TRH (100 nmol).
Fig. 2 Effect of a-ﬂuoromethylhistidine (FMH; 50 mg/kg, i.p.) on
hypothalamic histamine content in the 2 h after the administration. The
i.p. administration of FMH decreased histamine content in the TMN
signiﬁcantly. *p < 0.05 versus PBS.
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TRH alone. Administration of FMH alone did not affect
food intake (Fig. 3a). Similarly, TRH caused a 50%
reduction in food intake in control (wild-type) mice
(p < 0.01), whereas the same treatment of histamine-
depleted H1KO mice caused a signiﬁcantly smaller
(30%; p < 0.05) reduction in food intake (Fig. 3b).
Effects of TRH on hypothalamic histamine and t-MH
content
Central infusion of TRH increased the concentration of
histamine in the TMN (p < 0.01 versus control; Fig. 4a) and
increased the pargyline-induced accumulation of t-MH in the
TMN, VMH, and PVN in rats (p < 0.05 versus control;
Fig. 4b).
Effect of TRH administration into the TMN on t-MH
contents, HDC activity and HDC mRNA expression in
the TMN
Placement of the cannula was compared to the atlas of
Paxinos and Watson (Fig. 5a) (Paxinos and Watson 1986).
Fig. 5b shows a typical TRH-infused site in rats. It was
veriﬁed that the tip of guide cannula was just above the
TMN. No chronically implanted guide cannula was found to
touch or damage the tissue of a target locus. The insertion of
the thin infusion cannula did not cause excessive tissue
destruction. Microinfusion of TRH into the TMN increased
the t-MH content in TMN of the hypothalamus, but not in the
AH and cerebral cortex, compared with PBS infusion
(p < 0.05; Fig. 6a). Correspondingly, the activity of HDC
was also increased by administration of TRH compared with
(a)
(b)
Fig. 3 Anorexia induced by thyrotropin-releasing hormone (TRH) is
attenuated in rats pre-treated with a-ﬂuoromethylhistidine (FMH) and
in mice with targeted disruption of the histamine H1 receptor (H1KO
mice). (a) Food intake over 1 h in rats (n = 6 per group) treated with
PBS (third cerebroventricle (3vt) infusion), FMH (50 mg/kg, i.p.), TRH
(100 nmol; 3vt infusion), or both FMH and TRH. *p < 0.01 versus
PBS-treated controls and FMH-treated controls.
p < 0.05 versus
TRH-treated rats. (b) Food intake over 1 h in H1KO mice (n = 6 per
group) treated with PBS (lateral ventricle infusion) or TRH (100 nmol;
lvt infusion). *p < 0.05 versus PBS-treated controls (wild-type mice).
p < 0.05 versus PBS-treated controls (H1KO mice).
§p < 0.05 versus
TRH-treated wild-type mice.
(a)
(b)
Fig. 4 Effects of TRH on hypothalamic histamine and telemethylhis-
tamine (t-MH) content. 3vt infusion of TRH elevated the concentration
of histamine within the tuberomammillary nucleus (TMN) (a) and
increased the concentration of t-MH in the TMN, paraventricular
nucleus, and ventromedial hypothalamus (b). (a) Histamine concen-
trations in the hypothalamic nuclei of rats (n = 6 per group) treated by
3vt infusion with PBS or TRH (100 nmol). (b) Concentrations of t-MH
in the hypothalamic nuclei of rats treated as described for
(a). *p < 0.05 versus PBS-treated controls.
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sion was increased by microinfusion of TRH at 10 and
50 nmol into the TMN but not at 1 nmol dose of TRH.
Moreover, TRH at the dose of 1–50 nmol increased HDC
expression in a dose-dependent manner (Fig. 6c).
Immunohistochemical detection TRH-R1 and TRH-R2
in histaminergic neurons
Speciﬁc antibodies revealed that TRH-R2 (green) was
expressed within histaminergic cell bodies in the TMN of
rats (red, white arrows) (Fig. 7a), whereas there was no
expression of TRH-R1 (green) in histaminergic cell bodies
(red, white arrows) (Fig. 7b). The speciﬁcity of the labeling
was controlled by omitting the TRH-R1 or TRH-R2
antiserum. (Fig. 7c).
(a)
(b)
Fig. 5 Schema indicating the area of TMN in the hypothalamus and
histological identiﬁcation of cannula tips in a representative infusion
site stained by histamine neurons. TMN, tuberomammillary nucleus;
D3 V, dorsal third ventricle; LV, lateral ventricle; MRe, mammillary
recess of third ventricle. Tip of cannula was just above the TMN. Scale
bar: 200 lm.
(a)
(b)
(c)
Fig. 6 Effects of TRH injection into the TMN of the hypothalamus on
tele-methylhistamine (t-MH) contents, HDC activity and HDC mRNA
expression in the TMN. (a) Microinfusion of TRH (10 nmol) into the
TMN of the hypothalamus elevated the t-MH contents in the TMN, but
not in the AH and cerebral cortex. *p < 0.05 versus PBS-treated
controls. (b) Microinfusion of TRH (10 nmol) into the TMN signiﬁcantly
increased HDC activity in the TMN. *p < 0.05 versus PBS infusion. (c)
Expression of HDC in the TMN of TRH (1, 10, or 50 nmol) and PBS
groups with real-time RT-PCR. *p £ 0.05 versus PBS and TRH
(1 nmol) infusion, #p £ 0.05 versus TRH (10 nmol) infusion.
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The present study demonstrated that the central infusion of
TRH at 100 nmol not but 10 nmol induced suppression of
food intake. This ﬁnding is consistent with the previous
study showing that the central infusion of TRH (25, 50,
100 nmol) suppressed starvation-induced feeding in a dose
related manner (Suzuki et al. 1982). Moreover, the depletion
of neuronal histamine by pre-treatment with FMH attenuated
TRH-induced suppression of food intake. These results
suggest that endogenous neuronal histamine may mediate the
suppression of food intake by TRH. We showed previously
that hypothalamic neuronal histamine suppressed food intake
via H1 receptors within the VMH and PVN, both of which
are nuclei that are central to satietiation (Oohara et al. 1994).
Our ﬁnding in the present study that the anorexigenic effect
of TRH was also attenuated in H1KO mice is further
evidence that histamine and H1 receptors mediate TRH
signaling to suppress food intake.
The involvement of TRH–histamine signaling in suppress-
ing food intake was also demonstrated by our study that
hypothalamic histamine and t-MH concentrations exhibited
region-speciﬁc increased in response to the administration of
TRHandthiseffectofTRHwasdose-dependentintherangeof
10 to 500 nmol. Speciﬁcally, the increase in histamine
concentrationswasrestrictedtotheTMNandwasnotdetected
in any other hypothalamic nuclei. After pretreatment with
pargyline hydrochloride, infusion of TRH into the 3vt
increased the concentration of t-MH not only in the TMN
but also in the PVN and VMH, which indicated that TRH
induced an increase in histamine turnover within these nuclei.
It might be suggested TRH infusion did not affect
concentration of hypothalamic histamine in the hypothalamic
nucleus except the TMN because histamine levels measured
in present study included released histamine in the extraneu-
ronal space as well as intracellular histamine in the nerve
terminal and histamine is rapidly converted to its metabolite,
t-MH, in the brain (Oohara et al. 1994).
Moreover, microinfusion of TRH into the TMN increased
HDC activity and t-MH content in the TMN. The transme-
thylation of histamine into t-MH, a major metabolite of
histamine, and its subsequent deamination, is the major
metabolic pathway of histamine in the brain. Therefore, it is
much more informative to analyze histamine release by
measuring its metabolite than to rely on a measurement of the
brain histamine level itself. Pre-treatment with pargyline, an
inhibitor of monoamine oxidase B, is useful for this
assessment, as it induces the accumulation of t-MH in the
extraneuronal space (Oishi et al. 1987; Oohara et al. 1994,
1994).
The TMN contains the cell bodies of histaminergic
neurons, whereas the PVN and VMH are major projection
sites of histamine (Sakata and Yoshimatsu 1997). Based on
this anatomical scheme, we conclude that TRH increased
histamine turnover not only in cell bodies within the TMN
but also at the nerve terminals within the PVN and VMH.
The possibility that TRH directly modulated histamine
release at nerve terminals in these sites cannot be excluded;
however, it is likely that TRH activates histaminergic
neurons within the TMN, and thereafter induces histamine
release from the nerve terminals at projection sites because
TRH receptors are expressed on the cell bodies of histamin-
ergic neurons within the TMN.
TRH-R1 and TRH-R2 exhibit distinct expression patterns
within the brain. In general, TRH-R1 is localized to the
hypothalamus and brain stem, which supports a link between
TRH-R1 and vegetative and autonomic functions. In con-
trast, TRH-R2 mRNA is distributed widely throughout the
brain, including the cerebral cortex and reticular formation,
(a)
(b)
(c)
Fig. 7 Immunohistochemical detection of TRH receptors in hista-
minergic neurons within the TMN. (a) Histaminergic neurons (red,
white arrows) expressed TRH type 2 receptors (green). (b) Hista-
minergic neurons (red, white arrows) did not express TRH type 1
receptors (green). (c) Substitution of TRH-R1 or TRH-R2 antibodies
with normal serum and incubation with secondary antibody as for
double staining results in no detectable signal. Scale bar: 10 lm.
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cognition and the arousal system. In the present study, we
identiﬁed TRH-R2, but not TRH-R1, within the cell bodies
of histaminergic neurons within the TMN. TRH-containing
neurons project to the TMN (Airaksinen et al. 1992), and it is
well established that hypothalamic neuronal histamine regu-
lates the sleep–wake cycle via connections to the ventrolateral
preoptic area (the ‘‘sleep center’’) and orexinergic neurons
within the lateral hypothalamic area (Mignot et al. 2002;
Huang et al. 2007). Therefore, the TRH–TRH-R2–histamine
pathway may constitute a neuronal network that regulates
arousal.Inaddition,ourﬁndingssuggestthatthispathwayalso
contributes to the effects of TRH on feeding behavior.
Present study suggests that both orexin and TRH may be
able to stimulate histaminergic system. Orexin increases food
intake whereas TRH decreases it. Previous study reported
that the central administration of orexin-A caused a signif-
icant increase in locomotor activity, but not food intake
(Ishizuka et al. 2006). From these ﬁndings, it may be
concluded that the histaminergic system participates in
arousal state rather than feeding regulation by orexinergic
neurons. On the other hand, histaminergic system mediates
the TRH-induced suppression of feeding behavior partially.
The mechanism involved in the anorectic effect of TRH
except histaminergic system is uncertain, but it is possibility
that TRH might cause anorectic effect by activating TRH
receptors localized in the PVN and VMH, regions known to
be involved in control of food intake and the site of the so-
called satiety center, directly.
Leptin acts on the brain to inhibit food intake (Campﬁeld
et al. 1995). 3vt infusion of leptin increases histamine
turnover rate (Yoshimatsu et al. 2001). Leptin-induced
suppression of feeding was reported to be attenuated both
in rats whose histamine was depleted by FMH, a suicide
inhibitor of histamine synthesizing HDC enzyme, and in
H1KO mice (Yoshimatsu et al. 1998; Masaki et al. 2001).
Despite these ﬁndings, how leptin activates histamine-
containing neurons within the hypothalamus is not known.
Leptin receptor mRNA is expressed within the PVN (which
is where the cell bodies of neurons that release TRH are
located) but not in the TMN (which is the origin of
histaminergic neurons) (Flier and Maratos-Flier 1998; Mant-
zoros 1999; Nillni et al. 2000). Recently, we reported that
neurons that contain glucagon-like peptide 1 (GLP-1) and
corticotropin-releasing hormone may mediate leptin signaling
to histaminergic neurons within the TMN (Gotoh et al. 2005).
The results of the present study suggest that there is an
additional pathway that transmits leptin signals to the hista-
minergic system. Because leptin increases TRH expression in
the PVN (Flier and Maratos-Flier 1998; Mantzoros 1999;
Nillni et al. 2000), and in light of our ﬁnding a functional and
neuroanatomicallinkbetweenTRHandneuronalhistamine,it
is likely that leptin may activate histaminergic neurons
indirectly via neurons that release TRH.
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